ASBP — Aspire Biopharma Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Aspire Biopharma Holdings, fiscal year end - December 31st, millions except per share.

	2020 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:		10-K	10-K	10-K	10-K
Standards:	—	USG	USG	USG	USG
Status:	fx Preliminary	Final	Final	Final	Final
Cash
Cash and Short Term Investments	—	0.497	0	—	1
Net Total Receivables	—	—	—	0.036	—
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	—	1.1	0.081	0.046	1.31
Long Term Investments
Other Long Term Assets
Total Assets	—	300	20	6.71	1.31
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	—	0.303	0.403	15.6	7.59
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	—	11.1	0.403	15.6	7.69
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	—	289	19.6	-8.9	-6.38
Total Liabilities & Shareholders' Equity	—	300	20	6.71	1.31
Total Common Shares Outstanding